Teva UK Limited Comments on Department of Health Generic Substitution Outcome

CASTLEFORD, England, October 15, 2010 – Teva UK Limited, the UK's leading manufacturer of generic medicines, has
today commented on the Department of Health's (DH) decision not to implement
generic substitution in primary care.

Although deciding not to go ahead with generic substitution as the
original proposals stood, DH has indicated that it will … Read the original article on Gaea Times at : Teva UK Limited Comments on Department of Health Generic Substitution Outcome.